Development of an AI Platform for the Analysis of Sperm and Prediction of Their Clinical Potential
Spermy01
Development and Validation of an Artificial Intelligence Platform for the Analysis of Sperm Samples and Prediction of Their Clinical Potential
1 other identifier
observational
500
1 country
5
Brief Summary
Prospective, multicenter research study with a split-sample design on semen samples, without intervention, to develop an artificial intelligence platform for the analysis of sperm samples and prediction of their clinical potential, in 500 semen samples, in an in vitro study over 24 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2026
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 27, 2026
CompletedFirst Posted
Study publicly available on registry
March 6, 2026
CompletedStudy Start
First participant enrolled
March 18, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2028
June 12, 2026
April 1, 2026
1.9 years
February 27, 2026
June 10, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Predictive performance of AI models for reproductive outcomes
Area Under the Receiver Operating Characteristic Curve (AUC) and R² (for continuous outcomes) evaluating the ability of the AI model to predict fertilization rate, blastocyst development rate, and pregnancy outcomes using pseudonymized clinical and semen analysis data.
Up to confirmation of clinical pregnancy: approximately 6-8 weeks after embryo transfer.
Study Arms (2)
IVF/ICSI Cycles Using Partner Semen
Couples undergoing IVF/ICSI treatment using ejaculated partner semen
IVF/ICSI Cycles Using Donor Semen
Women undergoing IVF/ICSI treatment using donor semen
Interventions
Sperm samples will be processed by swim-up technique
Sperm samples will be processed by density gradient centrifugation
Sperm samples will be processed by HyperSperm
Eligibility Criteria
Men and women undergoing IVF/ICSI treatment at participating fertility clinics.
You may qualify if:
- Ability to provide a semen sample via masturbation
- Semen sample intended for use in an IVF/ICSI cycle
You may not qualify if:
- Current diagnosis of a sexually transmitted infection (STI)
- Previous diagnosis of hepatitis A, B, C, D, or HIV
- Prior participation in this study
- Participation in a clinical trial involving an intervention within the last 3 months
- Female participants:
- Urdengoing an IVF/ICSI cycle with partner or donor semen
- Prior participation in this study
- Participation in a clinical trial involving an intervention within the last 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fecundis Lab SLlead
Study Sites (5)
Eugin Barcelona
Barcelona, Barcelona, 08006, Spain
Fertty
Barcelona, Barcelona, 08010, Spain
CIRH
Barcelona, Barcelona, 08017, Spain
Fertilab Barcelona
Barcelona, Barcelona, 08017, Spain
Natuvitro
Barcelona, Barcelona, 08029, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mariona Rius Mas, PhD
Fertty
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 27, 2026
First Posted
March 6, 2026
Study Start
March 18, 2026
Primary Completion (Estimated)
February 1, 2028
Study Completion (Estimated)
February 1, 2028
Last Updated
June 12, 2026
Record last verified: 2026-04